【兵庫県神戸市】ケアミックス病院

• 当直なし
• 週4以下

【神戸市】健診・人間ドック◎常勤医師募集！

勤務地

兵庫県神戸市内（2か所）

給与

1000万円 ～ 1500万円 応相談

募集科目

一般内科

勤務内容

健診、読影
健診診察、人間ドック診察、結果説明（労災二次・特定健診・ドック）、
予防接種問診、胸部レントゲン読影、その他健診・ドックに関連する業務

・診察件数　AM100名前後、PM50名前後　※閑散期繁忙期で差あり

• 当直なし
• 週4以下
• オンコールなし

【神戸市】健診医募集！

勤務地

兵庫県神戸市中央区

給与

996万円 応相談

募集科目

一般内科

勤務内容

健診
＜巡回健診＞
　巡回エリア：兵庫県内（豊岡、赤穂、尼崎、淡路島含む）
　企業規模：中小企業メイン
　健診内容：一般健診（問診、聴打診）特定健診（問診、聴打診）

　診察、問診
　・対応目安：繁忙期…多くて1日140～150名　閑散期…1日100名程
　巡回で1日1～3件を担当

　1日のスケジュール
　・クリニックに集合⇒巡回バスにて出発⇒各事業所で健診⇒クリニックへ戻る（※直行直帰不可です）

　※豊岡・篠山へ出張あり（二泊三日）…月2～3回を常勤医師で分担
　⇒1日目：移動・到着後、健診
　　2日目：終日　健診
　　3日目：終日　健診、終了後クリニックへ移動

【兵庫県】MD求人

勤務地

兵庫県内

給与

1400万円 応相談

募集科目

一般内科、小児科、その他（アレルギー科、免疫科）、製薬会社

勤務内容

その他
対象科目：内科、小児科、アレルギー科、免疫科

Basic purpose of the job
Senior CPhL-Asia supports the clinical development in Asia of new drugs and further development of approved drugs with emphasis on the design and execution of the Clinical Pharmacology (CP)development strategy.
CPhL-Asia is accountable and responsible for communicating with regulatory authorities on CP topics and for CP aspects of drug submission in Asia (e.g., submission summaries).
CPhL-Asia may act as trial clinical Pharmacologist (TCP; see TCP job profile) for clinical studies in their own project or outside of their own projects.
CPhL-Asia may serve as Clin Pharm representative within various teams in Asia (Japan/China) in support of early integration of Japan/China into global development program. Post PoCP, they may serve as CP and TMCP representative in various Asian teams until submission and launch. CPhL-Asia will also serve as main TMCP representatives in all PMO projects in Asia.

Accountabilities
Ensure timely delivery of state-of-the-art Clinical Pharmacology scientific concepts for decision making throughout clinical drug development and registration in Asia including all necessary processes and documentation.
Ensures timely delivery of state-of-the-art Clinical Pharmacology strategy development and implementation.
Senior CPhL-Asia is responsible for defining the CP strategy (for instance, defining the drug-drug interaction liability or formulation development strategy for modified release) of assigned project. CPhL-Asia is also responsible for refining the CP strategy in a timely manner as new data become available during drug development. As part of the strategy, CPhL-Asia may define CP aspects in a clin trial protocol and for an eventual submission and further phase IV activities.
Senior CPhL-Asia contributes to the Clin Pharm section of official documents (e.g., Information Brochure (IB), label); CPhL-Asia engages with regulatory agencies on matters pertaining to CP during drug development and are responsible for supporting Asian submission and post-submission activities with Clin Pharm and Biopharm expertise.
Clinical development project representative
Act as Clin Pharm representative in trial and project teams and regulatory meetings.
CPhL-Asia serves as Clin Pharm representative within various teams in support of early integration of Japan/China into global development program. Post PoCP, they may serve as CP and TMCP representative in various Asian teams until submission and launch. CPhL-Asia may also serve as main TMCP representatives in all PMO projects in Asia.
When delegating a trial to TCP, a CPhL-Asia is expected to ensure that adequate amount of information on the project and trial are provided to the TCP.
For instance, a CPhL-Asia is expected to discuss study design and project standards with the TCP.
A CPhL-Asia may function as a TCP in certain studies or projects.
Driving science and innovation
CPhL-Asia leads clinical development trial and project overarching topics from TMCP (e.g. by focus group).
CPhL-Asia represents Clinical Pharmacology or TMCP in internal and external initiatives/working groups.
CPhL-Asia continuously scouts, evaluates (incl piloting) and implements new methods and strategies in the area of Clinical Pharmacology.
Strategic partnerships:
CPhL-Asia implements collaborations and strategic partnerships with external bodies. They organize and manage projects with external organizations (e.g. CROs, ARO).
CPhL-Asia may serve as subject matter expert (CP, Biopharm) in in –or outlicensing activities

Functional processes:
CPhL-Asia continuously develops and refines further functional processes and infrastructure.
CPhL-Asia is CP (CP and Biopharm) experts and may offer this expertise to other interface functions (e.g, Toxicology, Pharmacovigilance, Customer Information, Marketing, Regulatory Affairs) or to support internal or external working groups.
CPhL-Asia presents results internally and externally as well as contributes to scientific publications.

Compliance (incl GCP):
CPhL-Asia follows all ICH GCP, other relevant authority regulations and internal guidance to protect the rights, safety and wellbeing of trial subjects, including sample chain of custody, data privacy and data integrity. In addition, obligations outside the field of clinical studies, such as EHS, Pharmacovigilance, anti-corruption, BI-internal guidance should be followed.

• 高額年俸
• 週4以下
• 未経験歓迎

【兵庫県尼崎市】クリニック／訪問診療

勤務地

兵庫県尼崎市

給与

2100万円 ～ 2800万円 応相談

募集科目

内科全般（科目不問）、一般内科、外科全般（科目不問）、一般外科

勤務内容

在宅
【訪問割合】
居宅6・施設4

【訪問件数目安】
午前：2～6件程度
午後：2～6件程度

【訪問体制】
看護師または事務スタッフが同行
運転はドライバーまたは事務スタッフが担当

【オンコール対応体制】
① オンコール専門部署が一次対応
② 看護師が二次対応
③ 医師が必要時に三次対応
※オンコールは1か月に1週間程度ご対応いただきます。
（実績目安）
・常勤医師3名による当番制
・問い合わせ件数：1日2～3件程度
・出動：月3～4回程度
・年間看取り件数：20～30件程度
※オンコール負担が一人の医師に集中しにくい体制です。